Yulia V. Rogova

Yulia V. Rogova

Auto-generated profile, based on publicly available information

Yulia V. Rogova

Russian Acad Sci, Chumakov Fed Sci Ctr Res & Dev Immune & Biol Prod, Moscow 108819, Russia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2013 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DODmitry Osolodkin
Dmitry Osolodkin
LKLiubov Kozlovskaya
Liubov Kozlovskaya
EDEvgenia V. Dueva
Evgenia V. Dueva
VDVictor Dotsenko
Victor Dotsenko
YRYulia V. Rogova
Yulia V. Rogova
NZNikolay S. Zefirov
Nikolay S. Zefirov

1 March 2010 in Virology
Verified
Journal Article
Closed access
LKLiubov Kozlovskaya
Liubov Kozlovskaya
DODmitry Osolodkin
Dmitry Osolodkin
ASA.S. Shevtsova
A.S. Shevtsova
LRL.IU. Romanova
L.IU. Romanova
YRY.V. Rogova
Y.V. Rogova
GKG.G. Karganova
G.G. Karganova

1 April 2016 in Vaccine
Verified
Journal Article
Closed access
LCL.L. Chernokhaeva
L.L. Chernokhaeva
YRYu.V. Rogova
Yu.V. Rogova
MVM.F. Vorovitch
M.F. Vorovitch
LRL.IU. Romanova
L.IU. Romanova
LKLiubov Kozlovskaya
Liubov Kozlovskaya
GKGalina Karganova
Galina Karganova

9 April 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NPNatalia S. Pripuzova
Natalia S. Pripuzova
LGLarissa V. Gmyl
Larissa V. Gmyl
LRLidiya Iu. Romanova
Lidiya Iu. Romanova
NTNatalia V. Tereshkina
Natalia V. Tereshkina
YRYulia V. Rogova
Yulia V. Rogova
GKGalina Karganova
Galina Karganova
Tick-borne encephalitis virus (TBEV) is one of the most prevalent and medically important tick-borne arboviruses in Eurasia. There are overlapping foci of two flaviviruses: TBEV and Omsk hemorrhagic fever virus (OHFV) in Russia. Inactivated vaccines exist only against TBE. There are no antiviral drugs for treatment of both diseases. Optimal animal models are necessary to study efficacy of novel vaccines and treatment preparations against TBE and relative flaviviruses. The models for TBE and OHF using subcutaneous inoculation were tested in Cercopithecus aethiops and Macaca fascicularis monkeys with or without prior immunization with inactivated TBE vaccine. No visible clinical signs or severe pathomorphological lesions were observed in any monkey infected with TBEV or OHFV. C. aethiops challenged with OHFV showed massive hemolytic syndrome and thrombocytopenia. Infectious virus or viral RNA was revealed in visceral organs and CNS of C. aethiops infected with both viruses; however, viremia was low. Inactivated TBE vaccines induced high antibody titers against both viruses and expressed booster after challenge. The protective efficacy against TBE was shown by the absence of virus in spleen, lymph nodes and CNS of immunized animals after challenge. Despite the absence of expressed hemolytic syndrome in immunized C. aethiops TBE vaccine did not prevent the reproduction of OHFV in CNS and visceral organs. Subcutaneous inoculation of M. fascicularis with two TBEV strains led to a febrile disease with well expressed viremia, fever, and virus reproduction in spleen, lymph nodes and CNS. The optimal terms for estimation of the viral titers in CNS were defined as 8–16 days post infection. We characterized two animal models similar to humans in their susceptibility to tick-borne flaviviruses and found the most optimal scheme for evaluation of efficacy of preventive and therapeutic preparations. We also identified M. fascicularis to be more susceptible to TBEV than C. aethiops .

20 January 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
ASAnastasia S. Shevtsova
Anastasia S. Shevtsova
OMOxana V. Motuzova
Oxana V. Motuzova
VKVera M. Kuragina
Vera M. Kuragina
NANelli K. Akhmatova
Nelli K. Akhmatova
LGLarissa V. Gmyl
Larissa V. Gmyl
GKGalina Karganova
Galina Karganova
Tick-borne encephalitis virus (TBEV) is a tick-transmitted arbovirus that causes serious diseases in humans in Europe and Northern Asia. About 6,000-10,000 cases are registered annually, and one-third of them lead to sequela with different degrees of severity. Two TBEV strains (Absettarov and EK-328) similar in virulence rate in laboratory mice were used to study pathogenesis and immune response upon lethal infection in mice. The strains differed in the dynamics of appearance of virus, IFNs and other cytokines in blood of mice, and ability to induce a cytokine storm in the terminal stages of disease and a non-sterile immunity. Moreover, the TBEV strains differed in characteristics of their interactions with DCs: level of reproduction in these cells, virus dose triggering IFN-α production, and impact on DCs’ maturation. Infection of DCs with Absettarov strain led to IFN-α induction only at high multiplicity of infection (MOI), and an increased amount of the mature DCs with high adhesion activity and low-level of MHCII positive cells. While reproduction of the EK-328 strain in DCs was less efficient, a low dose of the virus induced IFN-α production and stimulated maturation of DCs with relatively low adhesive capacity, but with the high percentage of cells expressing MHCII molecules. Thus, the studied strains differed significantly in the impact on DCs’ maturation and antigen presentation to CD4+ lymphocytes. Injection of low (103 PFU) and high (106 PFU) doses of both TBEV strains caused a lethal infection in mice. At the same time, the dose of the virus in the inoculum, regardless of the strain properties, affected the following virulence characteristics: the time of virus appearance in brain (day 4-5 p.i. vs day 1 p.i.), time of IFN appearance in blood (10 h p.i. vs 5 h p.i.), concentration of IFN-α in blood, and induction of IFN-α during infection of DCs. Therefore, virulent TBEV strains during lethal infection can interact differently with the host immune system, and the infectious dose has an impact on both: virus spread in the infected organism and immune response activation.

28 October 2018 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
GMGalina B. Maikova
Galina B. Maikova
LCLiubov L. Chernokhaeva
Liubov L. Chernokhaeva
YRYulia V. Rogova
Yulia V. Rogova
LKLiubov I. Kozlovskaya
Liubov I. Kozlovskaya
IKIvan S. Kholodilov
Ivan S. Kholodilov
GKGalina Karganova
Galina Karganova